Shadi Farabi Maleki

Dr. Shadi Farabi Maleki


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2025 in Artificial Intelligence Review
Verified
Journal Article
Open access
PDF file
Ali JafarizadehAli Jafarizadeh
Ali Jafarizadeh
SMShadi Farabi Maleki
Shadi Farabi Maleki
PPParnia Pouya
Parnia Pouya
Navid SobhiNavid Sobhi
Navid Sobhi
MAMirsaeed Abdollahi
Mirsaeed Abdollahi
U Rajendra AcharyaU Rajendra Acharya
U Rajendra Acharya
Retinopathy of prematurity (ROP) is a severe condition affecting premature infants, leading to abnormal retinal blood vessel growth, retinal detachment, and potential blindness. While semi-automated systems have been used in the past to diagnose ROP-related plus disease by quantifying retinal vessel features, traditional machine learning (ML) models face challenges like accuracy and overfitting. Recent advancements in deep learning (DL), especially convolutional neural networks (CNNs), have significantly improved ROP detection and classification. The i-ROP deep learning (i-ROP-DL) system also shows promise in detecting plus disease, offering reliable ROP diagnosis potential. This research comprehensively examines the contemporary progress and challenges associated with using retinal imaging and artificial intelligence (AI) to detect ROP, offering valuable insights that can guide further investigation in this domain. Based on 84 original studies in this field (out of 2025 studies that were comprehensively reviewed), we concluded that traditional methods for ROP diagnosis suffer from subjectivity and manual analysis, leading to inconsistent clinical decisions. AI holds great promise for improving ROP management. This review explores AI’s potential in ROP detection, classification, diagnosis, and prognosis.
3

13 December 2023 in Seminars in Ophthalmology
Verified
Journal Article
Closed access
SMShadi Farabi Maleki
Shadi Farabi Maleki
MYMilad Yousefi
Milad Yousefi
SASayeh Afshar
Sayeh Afshar
Siamak PedrammehrSiamak Pedrammehr
Siamak Pedrammehr
Chee Peng LimChee Peng Lim
Chee Peng Lim
Houshyar AsadiHoushyar Asadi
Houshyar Asadi
Multiple sclerosis (MS) is a complex autoimmune disease characterized by inflammatory processes, demyelination, neurodegeneration, and axonal damage within the central nervous system (CNS). Retinal imaging, particularly Optical coherence tomography (OCT), has emerged as a crucial tool for investigating MS-related retinal injury. The integration of artificial intelligence(AI) has shown promise in enhancing OCT analysis for MS. Researchers are actively utilizing AI algorithms to accurately detect and classify MS-related abnormalities, leading to improved efficiency in diagnosis, monitoring, and personalized treatment planning. The prognostic value of AI in predicting MS disease progression has garnered substantial attention. Machine learning (ML) and deep learning (DL) algorithms can analyze longitudinal OCT data to forecast the course of the disease, providing critical information for personalized treatment planning and improved patient outcomes. Early detection of high-risk patients allows for targeted interventions to mitigate disability progression effectively. As such, AI-driven approaches yielded remarkable abilities in classifying distinct MS subtypes based on retinal features, aiding in disease characterization and guiding tailored therapeutic strategies. Additionally, these algorithms have enhanced the accuracy and efficiency of OCT image segmentation, streamlined diagnostic processes, and reduced human error. This study reviews the current research studies on the integration of AI,including ML and DL algorithms, with OCT in the context of MS. It examines the advancements, challenges, potential prospects, and ethical concerns of AI-powered techniques in enhancing MS diagnosis, monitoring disease progression, revolutionizing patient care, the development of patient screening tools, and supported clinical decision-making based on OCT images.
3

1 March 2024 in Current Alzheimer Research
Verified
Journal Article
Closed access
PDF file
SMShadi Farabi Maleki
Shadi Farabi Maleki
MYMilad Yousefi
Milad Yousefi
Navid SobhiNavid Sobhi
Navid Sobhi
Ali JafarizadehAli Jafarizadeh
Ali Jafarizadeh
RARoohallah Alizadehsani
Roohallah Alizadehsani
Juan M. Górriz SáezJuan M. Górriz Sáez
Juan M. Górriz Sáez
: As the world's population ages, Alzheimer's disease is currently the seventh most common cause of death globally; the burden is anticipated to increase, especially among middle-class and elderly persons. Artificial intelligence-based algorithms that work well in hospital environments can be used to identify Alzheimer's disease. A number of databases were searched for English-language articles published up until March 1, 2024, that examined the relationships between artificial intelligence techniques, eye movements, and Alzheimer's disease. A novel non-invasive method called eye movement analysis may be able to reflect cognitive processes and identify anomalies in Alzheimer's disease. Artificial intelligence, particularly deep learning, and machine learning, is required to enhance Alzheimer's disease detection using eye movement data. One sort of deep learning technique that shows promise is convolutional neural networks, which need further data for precise classification. Nonetheless, machine learning models showed a high degree of accuracy in this context. Artificial intelligence-driven eye movement analysis holds promise for enhancing clinical evaluations, enabling tailored treatment, and fostering the development of early and precise Alzheimer's disease diagnosis. A combination of artificial intelligence-based systems and eye movement analysis can provide a window for early and non-invasive diagnosis of Alzheimer's disease. Despite ongoing difficulties with early Alzheimer's disease detection, this presents a novel strategy that may have consequences for clinical evaluations and customized medication to improve early and accurate diagnosis.
3

30 November 2024 in DARU Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
NFNeda Feizi
Neda Feizi
MMMahsa Mohamadzadeh-Nabiei
Mahsa Mohamadzadeh-Nabiei
Hadi VahediHadi Vahedi
Hadi Vahedi
SMShadi Farabi Maleki
Shadi Farabi Maleki
Ali JafarizadehAli Jafarizadeh
Ali Jafarizadeh
3

9 April 2024 in arXiv
Verified
Preprint
Open access
PDF file
MYMilad Yousefi
Milad Yousefi
SMShadi Farabi Maleki
Shadi Farabi Maleki
Ali JafarizadehAli Jafarizadeh
Ali Jafarizadeh
MYMahya Ahmadpour Youshanlui
Mahya Ahmadpour Youshanlui
AJAida Jafari
Aida Jafari
Pawel PlawiakPawel Plawiak
Pawel Plawiak
Thyroid cancer is an increasing global health concern that requires advanced diagnostic methods. The application of AI and radiomics to thyroid cancer diagnosis is examined in this review. A review of multiple databases was conducted in compliance with PRISMA guidelines until October 2023. A combination of keywords led to the discovery of an English academic publication on thyroid cancer and related subjects. 267 papers were returned from the original search after 109 duplicates were removed. Relevant studies were selected according to predetermined criteria after 124 articles were eliminated based on an examination of their abstract and title. After the comprehensive analysis, an additional six studies were excluded. Among the 28 included studies, radiomics analysis, which incorporates ultrasound (US) images, demonstrated its effectiveness in diagnosing thyroid cancer. Various results were noted, some of the studies presenting new strategies that outperformed the status quo. The literature has emphasized various challenges faced by AI models, including interpretability issues, dataset constraints, and operator dependence. The synthesized findings of the 28 included studies mentioned the need for standardization efforts and prospective multicenter studies to address these concerns. Furthermore, approaches to overcome these obstacles were identified, such as advances in explainable AI technology and personalized medicine techniques. The review focuses on how AI and radiomics could transform the diagnosis and treatment of thyroid cancer. Despite challenges, future research on multidisciplinary cooperation, clinical applicability validation, and algorithm improvement holds the potential to improve patient outcomes and diagnostic precision in the treatment of thyroid cancer.
3

1 January 2026 in Case Reports in Ophthalmological Medicine
Verified
Journal Article
Open access
EBElizabeth A. Bradley
Elizabeth A. Bradley
RNReza Nabie
Reza Nabie
SMShadi Farabi Maleki
Shadi Farabi Maleki
Spindle cell carcinoma, also known as carcinosarcoma or sarcomatoid carcinoma, is a rare and aggressive variant of squamous cell carcinoma known by biphasic malignant histology with epithelial and mesenchymal differentiation. We report the case of a 72‐year‐old male presenting with progressive unilateral proptosis, upper eyelid swelling, and restricted ocular motility. Imaging showed a well‐defined mass infiltrating multiple orbital structures, histopathologically supporting orbital spindle cell carcinoma after ruling out other mimics. After surgical debulking, followed by chemotherapy and radiotherapy, the tumor showed aggressive invasion with local infiltration, bone destruction, and intracranial extension, which ultimately led to the patient′s death. This case underscores detection and management challenges in the primary orbital spindle cell carcinoma. This tumor′s aggressiveness and resistance to traditional treatment approaches reveal the need for further investigation into its etiology and better management techniques.